Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2017, Article ID 5753039, 10 pages
https://doi.org/10.1155/2017/5753039
Clinical Study

Benefits of Levothyroxine Replacement Therapy on Nonalcoholic Fatty Liver Disease in Subclinical Hypothyroidism Patients

Lu Liu,1,2,3 Yong Yu,4 Meng Zhao,1,2,3 Dongmei Zheng,1,2,3 Xu Zhang,1,2,3 Qingbo Guan,1,2,3 Chao Xu,1,2,3 Ling Gao,2,3,5 Jiajun Zhao,1,2,3 and Haiqing Zhang1,2,3

1Department of Endocrinology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong 250021, China
2Shandong Clinical Medical Center of Endocrinology and Metabolism, Jinan, Shandong 250021, China
3Institute of Endocrinology and Metabolism, Shandong Academy of Clinical Medicine, Jinan, Shandong 250021, China
4Department of Sonography, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong 250021, China
5Scientific Center, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong 250021, China

Correspondence should be addressed to Haiqing Zhang; moc.361@6757gnahzgniqiah

Received 7 September 2016; Revised 22 November 2016; Accepted 15 December 2016; Published 4 April 2017

Academic Editor: Paul M. Yen

Copyright © 2017 Lu Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Angulo, “GI epidemiology: nonalcoholic fatty liver disease,” Alimentary Pharmacology and Therapeutics, vol. 25, no. 8, pp. 883–889, 2007. View at Publisher · View at Google Scholar
  2. J. Frith, C. P. Day, E. Henderson, A. D. Burt, and J. L. Newton, “Non-alcoholic fatty liver disease in older people,” Gerontology, vol. 55, no. 6, pp. 607–613, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Zelber-Sagi, D. Nitzan-Kaluski, Z. Halpern, and R. Oren, “Prevalence of primary non-alcoholic fatty liver disease in a population-based study and its association with biochemical and anthropometric measures,” Liver International, vol. 26, no. 7, pp. 856–863, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. M. R. Charlton, J. M. Burns, R. A. Pedersen, K. D. Watt, J. K. Heimbach, and R. A. Dierkhising, “Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States,” Gastroenterology, vol. 141, no. 4, pp. 1249–1253, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Liu and H. Y. Lu, “Nonalcoholic fatty liver disease and cardiovascular disease,” World Journal of Gastroenterology, vol. 20, no. 26, pp. 8407–8415, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. K. C. Sung and S. H. Kim, “Interrelationship between fatty liver and insulin resistance in the development of type 2 diabetes,” Journal of Clinical Endocrinology and Metabolism, vol. 96, no. 4, pp. 1093–1097, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Hardy, Q. M. Anstee, and C. P. Day, “Nonalcoholic fatty liver disease: new treatments,” Current Opinion in Gastroenterology, vol. 31, no. 3, pp. 175–183, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. V. W. Wong, R. S. Chan, G. L. Wong et al., “Community-based lifestyle modification programme for non-alcoholic fatty liver disease: a randomized controlled trial,” Journal of Hepatology, vol. 59, no. 3, pp. 536–542, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. A. P. Weetman, “Hypothyroidism: screening and subclinical disease,” BMJ, vol. 314, no. 7088, pp. 1175–1178, 1997. View at Publisher · View at Google Scholar
  10. W. M. Tunbridge, D. C. Evered, R. Hall et al., “The spectrum of thyroid disease in a community: the Whickham survey,” Clinical Endocrinology, vol. 7, no. 6, pp. 481–493, 1977. View at Publisher · View at Google Scholar
  11. R. K. Marwaha, N. Tandon, M. A. Ganie et al., “Status of thyroid function in Indian adults: two decades after universal salt iodization,” Journal of the Association of Physicians of India, vol. 60, pp. 32–36, 2012. View at Publisher · View at Google Scholar
  12. “Thyroid disease—more research needed,” Lancet, vol. 379, no. 9821, p. 1076, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. G. E. Chung, D. Kim, W. Kim et al., “Non-alcoholic fatty liver disease across the spectrum of hypothyroidism,” Journal of Hepatology, vol. 57, no. 1, pp. 150–156, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. L. Xu, H. Ma, M. Miao, and Y. Li, “Impact of subclinical hypothyroidism on the development of non-alcoholic fatty liver disease: a prospective case-control study,” Journal of Hepatology, vol. 57, no. 5, pp. 1153–1154, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Xu, L. Xu, C. Yu, M. Miao, and Y. Li, “Association between thyroid function and nonalcoholic fatty liver disease in euthyroid elderly Chinese,” Clinical Endocrinology, vol. 75, no. 2, pp. 240–246, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. W. J. Ding, M. M. Wang, G. S. Wang, F. Shen, J. J. Qin, and J. G. Fan, “Thyroid function is associated with non-alcoholic fatty liver disease in chronic hepatitis B-infected subjects,” Journal of Gastroenterology and Hepatology, vol. 30, no. 12, pp. 1753–1758, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. W. Zhang, L. M. Tian, Y. Han et al., “Presence of thyrotropin receptor in hepatocytes: not a case of illegitimate transcription,” Journal of Cellular and Molecular Medicine, vol. 13, no. 11-12, pp. 4636–4642, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. F. Yan, Q. Wang, M. Lu et al., “Thyrotropin increases hepatic triglyceride content through upregulation of SREBP-1c activity,” Journal of Hepatology, vol. 61, no. 6, pp. 1358–1364, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. L. Tian, Y. Song, M. Xing et al., “A novel role for thyroid-stimulating hormone: up-regulation of hepatic 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase expression through the cyclic adenosine monophosphate/protein kinase A/cyclic adenosine monophosphate-responsive element binding protein pathway,” Hepatology, vol. 52, no. 4, pp. 1401–1409, 2010. View at Google Scholar
  20. J. Karmisholt, S. Andersen, and P. Laurberg, “Weight loss after therapy of hypothyroidism is mainly caused by excretion of excess body water associated with myxoedema,” Journal of Clinical Endocrinology and Metabolism, vol. 96, no. 1, pp. E99–103, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Zhao, L. Liu, F. Wang et al., “A worthy finding: decrease in total cholesterol and low-density lipoprotein cholesterol in treated mild subclinical hypothyroidism,” Thyroid, vol. 26, no. 8, pp. 1019–1029, 2016. View at Publisher · View at Google Scholar
  22. F. Wang, Y. Tan, C. Wang et al., “Thyroid-stimulating hormone levels within the reference range are associated with serum lipid profiles independent of thyroid hormones,” Journal of Clinical Endocrinology and Metabolism, vol. 97, no. 8, pp. 2724–2731, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Xu, X. Yang, W. Liu et al., “Thyroid stimulating hormone, independent of thyroid hormone, can elevate the serum total cholesterol level in patients with coronary heart disease: a cross-sectional design,” Nutrition & Metabolism (London), vol. 9, no. 1, p. 44, 2012. View at Publisher · View at Google Scholar
  24. N. Assy, K. Kaita, D. Mymin, C. Levy, B. Rosser, and G. Minuk, “Fatty infiltration of liver in hyperlipidemic patients,” Digestive Diseases and Sciences, vol. 45, no. 10, pp. 1929–1934, 2000. View at Publisher · View at Google Scholar · View at Scopus
  25. C. H. Chen, M. H. Huang, J. C. Yang et al., “Prevalence and risk factors of nonalcoholic fatty liver disease in an adult population of Taiwan: metabolic significance of nonalcoholic fatty liver disease in nonobese adults,” Journal of Clinical Gastroenterology, vol. 40, no. 8, pp. 745–752, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Hamaguchi, T. Kojima, N. Takeda et al., “The metabolic syndrome as a predictor of nonalcoholic fatty liver disease,” Annals of Internal Medicine, vol. 143, no. 10, pp. 722–728, 2005. View at Publisher · View at Google Scholar
  27. J. R. Garber, R. H. Cobin, H. Gharib et al., “Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association,” Endocrine Practice, vol. 18, no. 6, pp. 988–1028, 2012. View at Publisher · View at Google Scholar
  28. Y. Xu, L. Wang, J. He et al., “Prevalence and control of diabetes in Chinese adults,” JAMA, vol. 310, no. 9, pp. 948–959, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. O. W. Hamer, D. A. Aguirre, G. Casola, J. E. Lavine, M. Woenckhaus, and C. B. Sirlin, “Fatty liver: imaging patterns and pitfalls,” Radiographics, vol. 26, no. 6, pp. 1637–1653, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. M. D. Zeng, J. G. Fan, L. G. Lu et al., “Guidelines for the diagnosis and treatment of nonalcoholic fatty liver diseases,” Journal of Digestive Diseases, vol. 9, no. 2, pp. 108–112, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. D. Joy, V. R. Thava, and B. B. Scott, “Diagnosis of fatty liver disease: is biopsy necessary?” European Journal of Gastroenterology and Hepatology, vol. 15, no. 5, pp. 539–543, 2003. View at Publisher · View at Google Scholar
  32. K. G. Alberti and P. Z. Zimmet, “Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation,” Diabetic Medicine, vol. 15, no. 7, pp. 539–553, 1998. View at Publisher · View at Google Scholar
  33. E. National Cholesterol Education Program Expert Panel on Detection, A. Treatment of High Blood Cholesterol, “Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report,” Circulation, vol. 106, no. 25, pp. 3143–3421, 2002. View at Google Scholar
  34. K. L. Hsueh and C. M. Chen, Guideline for Prevention and Control of Overweight and Obesity in Adult, People's Medical Publishing House, Beijing, 2006.
  35. V. Velkoska Nakova, B. Krstevska, M. Bosevski, C. Dimitrovski, and V. Serafimoski, “Dyslipidaemia and hypertension in patients with subclinical hypothyroidism,” Prilozi. Contributions, vol. 30, no. 2, pp. 93–102, 2009. View at Google Scholar
  36. D. C. Bauer, B. Ettinger, and W. S. Browner, “Thyroid functions and serum lipids in older women: a population-based study,” American Journal of Medicine, vol. 104, no. 6, pp. 546–551, 1998. View at Publisher · View at Google Scholar · View at Scopus
  37. J. Y. Wu, X. Y. Duan, L. Li et al., “Dyslipidemia in shanghai, China,” Preventive Medicine, vol. 51, no. 5, pp. 412–415, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. Y. Y. Fu, J. M. Yu, J. H. Wang et al., “Prevalence and awareness of dyslipidemia among overweight and obese population in Beijing community,” Zhonghua Xin Xue Guan Bing Za Zhi, vol. 38, no. 6, pp. 562–566, 2010. View at Google Scholar
  39. E. K. Speliotes, J. M. Massaro, U. Hoffmann et al., “Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study,” Hepatology, vol. 51, no. 6, pp. 1979–1987, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. J. Chan, F. E. Sharkey, R. S. Kushwaha, J. F. Vande Berg, and J. L. Vande Berg, “Steatohepatitis in laboratory opossums exhibiting a high lipemic response to dietary cholesterol and fat,” American Journal of Physiology. Gastrointestinal and Liver Physiology, vol. 303, no. 1, pp. G12–G19, 2012. View at Google Scholar
  41. P. Simonen, A. Kotronen, M. Hallikainen et al., “Cholesterol synthesis is increased and absorption decreased in non-alcoholic fatty liver disease independent of obesity,” Journal of Hepatology, vol. 54, no. 1, pp. 153–159, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Zelber-Sagi, F. Salomone, H. Yeshua et al., “Non-high-density lipoprotein cholesterol independently predicts new onset of non-alcoholic fatty liver disease,” Liver International, vol. 34, no. 6, pp. e128–e135, 2014. View at Publisher · View at Google Scholar · View at Scopus
  43. S. Milic, D. Lulic, and D. Stimac, “Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations,” World Journal of Gastroenterology, vol. 20, no. 28, pp. 9330–9337, 2014. View at Publisher · View at Google Scholar · View at Scopus
  44. K. Promrat, D. E. Kleiner, H. M. Niemeier et al., “Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis,” Hepatology, vol. 51, no. 1, pp. 121–129, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. S. Saadeh, Z. M. Younossi, E. M. Remer et al., “The utility of radiological imaging in nonalcoholic fatty liver disease,” Gastroenterology, vol. 123, no. 3, pp. 745–750, 2002. View at Publisher · View at Google Scholar · View at Scopus
  46. J. Y. Lee, K. M. Kim, S. G. Lee et al., “Prevalence and risk factors of non-alcoholic fatty liver disease in potential living liver donors in Korea: a review of 589 consecutive liver biopsies in a single center,” Journal of Hepatology, vol. 47, no. 2, pp. 239–244, 2007. View at Publisher · View at Google Scholar · View at Scopus